Welcome to our dedicated page for Abacus Global Management news (Ticker: ABL), a resource for investors and traders seeking the latest updates and insights on Abacus Global Management stock.
Abacus Life Inc (ABL) provides investors with centralized access to essential corporate developments through this comprehensive news resource. Our curated collection features official announcements, strategic updates, and financial disclosures directly relevant to the company's operations in life insurance asset management.
Visitors gain immediate access to critical information including earnings reports, partnership announcements, and regulatory updates. The repository serves both active traders monitoring short-term developments and long-term investors analyzing market positioning within the alternative assets sector.
All content undergoes verification to ensure alignment with SEC regulations and corporate disclosure standards. Users can efficiently track ABL's vertical integration strategy implementation, portfolio management updates, and risk assessment methodologies through chronologically organized releases.
Bookmark this page for streamlined monitoring of ABL's evolving position in life insurance investments. Combine this resource with our financial analysis tools> for complete market perspective (remove promotional reference if required).
Abacus Global Management (NASDAQ: ABL) reported outstanding Q2 2025 results with total revenue nearly doubling to $56.2 million, up 93% year-over-year. The company achieved GAAP net income of $17.6 million and Adjusted EBITDA growth of 89% to $31.5 million.
Key highlights include $123.1 million in Longevity Funds capital inflows, origination capital deployment of $121.8 million, and a portfolio of 600 policies. The company announced a $20 million share repurchase program and raised its full-year 2025 Adjusted net income guidance to $74-80 million, representing 59-72% growth.
Post-quarter, Abacus completed its warrant exchange offer, resulting in approximately 102.6 million shares outstanding, representing a 5% increase.
Abacus Global Management (NASDAQ: ABL) has successfully completed its previously announced exchange offer and consent solicitation for its outstanding public and private placement warrants. The company issued 4,183,160 shares of common stock in exchange for tendered warrants.
Through a Warrant Amendment, Abacus will conduct a Post-Offer Exchange on August 14, 2025, exchanging remaining warrants at a ratio of 0.207 shares per warrant. Following these transactions, no warrants will remain outstanding, and public warrants (ABLLW) will be delisted from Nasdaq. The total shares outstanding will increase to approximately 102,555,154, representing a 5% increase.
Abacus Global Management (NASDAQ: ABL) has successfully completed its warrant exchange offer and consent solicitation. The company received tenders for 18,188,277 warrants, representing approximately 88% of outstanding warrants, before the offer's expiration on July 29, 2025.
The consent solicitation garnered approval from 83% of public warrant holders and 94% of private placement warrant holders to amend the warrant agreement, surpassing the required 50% threshold. Following this success, Abacus will exchange remaining warrants at a ratio of 0.207 shares of common stock per warrant, which is 10% less than the original exchange offer ratio.
Abacus Global Management (NASDAQ: ABL), an alternative asset management company, has scheduled its second quarter 2025 financial results announcement for Thursday, August 7, 2025, after market close.
The company will host a conference call at 5:00 PM ET on the same day to discuss the results. Investors can access the call through a toll-free number (844) 826-3033 or international number (412) 317-5185. A live webcast will be available on the company's investor relations website, with a replay accessible for one year following the call.
Coventry has responded to a lawsuit filed by Abacus Global Management (NASDAQ: ABL), characterizing it as a diversionary tactic. Coventry's Chairman Alan Buerger maintains that Lapetus, in which Abacus holds a minority stake, systematically underestimates life expectancies, potentially impacting investor returns.
The response highlights apparent contradictions between Abacus's lawsuit claims and their SEC filings. While Abacus's complaint states they don't rely on Lapetus's life expectancy estimates for policy valuations, their SEC documents indicate otherwise, including statements about using Lapetus as their "primary life expectancy provider" for their new fund.
Coventry also denies any connection to Morpheus Research, which previously published a short report on Abacus, and maintains confidence in their position regarding the lawsuit's lack of merit.
Abacus Global Management (NASDAQ: ABL), a leader in alternative asset management, has filed a lawsuit against Coventry First LLC and its Chairman Alan Buerger for defamation and anticompetitive conduct in Florida's Ninth Circuit Court. The lawsuit alleges that Coventry and Buerger orchestrated a systematic campaign to spread false information about Abacus's valuation practices, culminating in a short report by Morpheus Research on June 4, 2025.
The legal action details how Coventry's campaign led to a 21% drop in Abacus's stock price, erasing over $200 million in market capitalization. Abacus claims Coventry spread misleading information to regulators, auditors, analysts, and investors, particularly regarding Abacus's use of Lapetus Solutions for life expectancy estimates.
Abacus CEO Jay Jackson emphasizes that the company's transparent pricing model has been validated by market transactions, with policies consistently selling to sophisticated investors like KKR at prices exceeding Abacus's valuations. The company is seeking hundreds of millions in damages for harm to its reputation, customer base, and investor relationships.
Abacus Global Management (NASDAQ: ABL) has launched an exchange offer and consent solicitation for its outstanding public and private placement warrants. The company is offering 0.23 shares of common stock for each warrant tendered, with a total offering of up to 4,743,381 shares of common stock in exchange.
The exchange offer will run until July 29, 2025. Concurrently, Abacus is seeking consent to amend the warrant agreement to require remaining warrant holders to exchange their warrants for 0.207 shares of common stock, a 10% reduction from the current offer ratio. Currently, parties representing 25% of public warrants and 94% of private placement warrants have agreed to the exchange.
As of June 30, 2025, Abacus has 97,867,821 shares of common stock outstanding and 20,623,395 total warrants. If all warrant holders participate, the company would issue approximately 4.7 million new shares, increasing the total outstanding shares by about 5% to 102,611,202.
Abacus Global Management (NASDAQ: ABL) has announced plans to conduct an exchange offer and consent solicitation for its outstanding warrants. The company is offering 0.23 shares of common stock for each warrant tendered in the exchange. Additionally, ABL is seeking consent to amend the Warrant Agreement to require remaining warrant holders to exchange their warrants for 0.207 shares of common stock, a 10% lower ratio than the initial offer.
Currently, each warrant allows holders to purchase one common share at $11.50 per share. The amendment would require approval from at least 50% of public warrant holders. The exchange offer will commence following the filing of a Form S-4 registration statement.
FAQ
What is the current stock price of Abacus Global Management (ABL)?
What is the market cap of Abacus Global Management (ABL)?
